1998
Immunohistologic Evaluation of Putatively Mutant p53 Protein in Cutaneous Melanocytic Neoplasms
Kaleem Z, Lind A, Humphrey P, Swanson P, Sueper R, Ritter J, Wick M. Immunohistologic Evaluation of Putatively Mutant p53 Protein in Cutaneous Melanocytic Neoplasms. International Journal Of Surgical Pathology 1998, 6: 73-79. DOI: 10.1177/106689699800600203.Peer-Reviewed Original ResearchImmunohistologic evaluationMutant p53 proteinNuclear labelingMelanocytic neoplasmsLentigo maligna melanomaP53 proteinHigh-power microscopic fieldCutaneous melanocytic neoplasmsBenign melanocytic neoplasmsP53 tumor suppressor geneMaligna melanomaNodular melanomaMalignant melanomaLatter lesionsMelanocytic proliferationMelanomaHuman malignanciesMelanocytic lesionsTumor suppressor geneSpitz neviCommon neviGenetic alterationsNeviMp53Neoplasms
1994
Overexpression of p53 Is Not a Feature of Benign and Early-Stage Borderline Epithelial Ovarian Tumors
Berchuck A, Kohler M, Hopkins M, Humphrey P, Robboy S, Rodriguez G, Soper J, Clarke-Pearson D, Bast R. Overexpression of p53 Is Not a Feature of Benign and Early-Stage Borderline Epithelial Ovarian Tumors. Gynecologic Oncology 1994, 52: 232-236. PMID: 7508877, DOI: 10.1006/gyno.1994.1037.Peer-Reviewed Original ResearchConceptsEpithelial ovarian tumorsOverexpression of p53Borderline epithelial ovarian tumorsEpithelial ovarian cancerOvarian tumorsBorderline tumorsOvarian cancerEarly-stage borderline ovarian tumorsStage I/II casesBenign epithelial ovarian tumorsInvasive epithelial ovarian cancerBorderline ovarian tumorsBenign ovarian tumorsStage III casesAdvanced stage casesBenign tumorsMutant p53 proteinP53 tumor suppressor gene productIII casesStage casesTumorsII casesP53 proteinTumor suppressor gene productP53